Sergio Salmeron, MD; Francois Brenot, MD; Bernardette Rain, MD; Michel Peuchemaur, MD; Philippe Herve, MD; Gerald Simonneau, MD; Pierre Duroux, MD; Bernard Rouveix, MD
This content is PDF only. Please click on the PDF icon to access.
To the Editor: Maprotiline (Ludiomil, Ciba Pharmaceutical Company, Summit, New Jersey) is a new tetracyclic antidepressant agent widely used in the United States and in Europe. The allergic side effects reported have included skin reactions and abnormal blood values (1). We report a case of allergic alveolitis related to maprotiline treatment.
A 66-year-old man was hospitalized with fever and dyspnea. The patient was in good health except for mild depression, and he had been taking maprotiline, 75 mg/d, for the previous 2 months. After 3 weeks of treatment, he had a fever (38.2 °C) and malaise. Because of tremors, trihexyphenidyl
Salmeron S, Brenot F, Rain B, et al. Maprotiline and Pulmonary Alveolitis. Ann Intern Med. 1988;109:758–759. doi: https://doi.org/10.7326/0003-4819-109-9-758_2
Download citation file:
Published: Ann Intern Med. 1988;109(9):758-759.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use